The "PHOX2B Gene Central Hypoventilation Syndrome with or Without Hirschsprung Disease Genetic Test" is a specialized diagnostic assessment conducted at DNA Labs UAE. This genetic test is specifically designed to identify mutations in the PHOX2B gene, which are known to cause Congenital Central Hypoventilation Syndrome (CCHS), a rare disorder affecting the autonomic control of breathing, and in some cases, is also associated with Hirschsprung disease, a condition that affects the large intestine and causes problems with passing stool.
The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the PHOX2B gene. Identifying these mutations can be crucial for the accurate diagnosis, management, and treatment planning for affected individuals, providing vital information on the conditions' progression and the best course of action for patient care.
DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures high precision and reliability in the test results, making it a trusted choice for patients and healthcare providers seeking comprehensive genetic testing services.
The ASCL1 Gene Central Hypoventilation Syndrome Congenital Genetic Test is a specialized diagnostic procedure designed to identify mutations in the ASCL1 gene, which are associated with Congenital Central Hypoventilation Syndrome (CCHS). CCHS is a rare genetic disorder that affects the autonomic control of breathing, causing individuals to hypoventilate, especially during sleep, leading to insufficient oxygen levels and an excess of carbon dioxide in the blood. The test is crucial for early diagnosis and management of the condition, which can significantly improve the quality of life and prognosis for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the ASCL1 gene. This gene plays a vital role in the development of the nervous system, including the neural networks responsible for controlling breathing.
The cost of the ASCL1 Gene Central Hypoventilation Syndrome Congenital Genetic Test is set at 4400 AED. While the price may seem significant, the test provides invaluable information for the diagnosis, treatment planning, and family counseling for those affected by CCHS. Early and accurate diagnosis through this genetic test can lead to timely interventions, reducing the risk of complications associated with the syndrome and improving the overall outcomes for patients.
The PITX2 Gene Axenfeld-Rieger Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the PITX2 gene, which are associated with Axenfeld-Rieger Syndrome Type 1 (ARS1). Axenfeld-Rieger Syndrome is a rare genetic disorder characterized by abnormalities in the development of the eyes, teeth, and abdominal region, potentially leading to glaucoma and vision loss. The PITX2 gene plays a crucial role in the early development of these structures, and mutations in this gene can disrupt normal development, leading to the manifestations of ARS1.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the PITX2 gene. It is a critical tool for genetic counseling, early diagnosis, and management of the syndrome, allowing for targeted interventions to mitigate some of the complications associated with the condition.
The cost of the PITX2 Gene Axenfeld-Rieger Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the genetic mutation, offering invaluable information for affected individuals and their families. Through this testing, families can gain a better understanding of the condition, its potential impact, and the genetic risks for future offspring, thereby facilitating informed decisions about health and family planning.
The FOXC1 gene Axenfeld-Rieger Syndrome Type 3 genetic test is a specialized diagnostic tool used to identify mutations in the FOXC1 gene, which are associated with Axenfeld-Rieger Syndrome Type 3 (ARS3). ARS3 is a rare genetic disorder characterized by various developmental issues, primarily affecting the eyes, teeth, and abdominal region. Individuals with this condition may experience glaucoma, dental anomalies, and umbilical hernia, among other symptoms.
This genetic test is crucial for early diagnosis and management of the syndrome, allowing for tailored treatment plans that can significantly improve the quality of life for affected individuals. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and reliability in results. The cost of the FOXC1 gene Axenfeld-Rieger Syndrome Type 3 genetic test is 4400 AED, reflecting the advanced technology and expertise required to perform this sophisticated analysis. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling informed decisions regarding healthcare and management of the syndrome.
The ASXL3 gene Bainbridge-Ropers Syndrome (BRPS) genetic test is a specialized diagnostic tool used to identify mutations in the ASXL3 gene, which are associated with Bainbridge-Ropers Syndrome. BRPS is a rare genetic disorder characterized by developmental delays, intellectual disability, difficulties with speech and language, and distinctive facial features. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene is sufficient to cause the disorder.
The test involves analyzing the patient's DNA, extracted from a blood sample, to search for specific mutations in the ASXL3 gene that are known to cause the syndrome. This test is crucial for confirming a diagnosis of BRPS, which can help in the management and treatment of the condition. Early diagnosis can also guide decisions regarding educational and therapeutic interventions.
The ASXL3 gene Bainbridge-Ropers Syndrome genetic test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. By opting for this test at DNA Labs UAE, patients and their families can expect reliable results, comprehensive support, and guidance on the implications of the findings for the patient's health and care.
The "OCLN Gene Band-Like Calcification with Simplified Gyration and Polymicrogyria Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the OCLN gene. These mutations are associated with a rare neurological disorder characterized by band-like calcifications in the brain, simplified gyration, and polymicrogyria, a condition where the brain has many small and irregular folds. This condition can lead to a variety of neurological symptoms and developmental delays. The test involves analyzing the patient's DNA to identify any genetic alterations in the OCLN gene that could lead to this disorder. The cost of the test is 4400 AED, making it a valuable tool for families seeking answers to complex neurological conditions. By providing a definitive genetic diagnosis, this test can help guide treatment decisions and support services for affected individuals.
The ACTB Gene Baraitser-Winter Syndrome Type 1 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the ACTB gene, which are responsible for Baraitser-Winter Syndrome Type 1. This rare genetic disorder is characterized by distinctive facial features, intellectual disability, and various developmental anomalies. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify specific genetic alterations in the ACTB gene, offering crucial information for accurate diagnosis, management, and understanding the risk of passing the condition to future generations. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a critical tool for families and individuals dealing with the implications of this syndrome, providing them with the necessary genetic insights to navigate the condition.
The ACTG1 Gene Baraitser-Winter Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the ACTG1 gene, which are associated with Baraitser-Winter Syndrome Type 2. This condition is a rare genetic disorder characterized by distinctive facial features, intellectual disability, and abnormalities in brain structure. The test plays a crucial role in confirming the diagnosis, enabling early intervention and tailored management plans for affected individuals. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to identify specific mutations in the ACTG1 gene, providing valuable insights for families and healthcare professionals in managing and understanding the condition's implications.
The PTCH1 Gene Basal Cell Nevus Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the PTCH1 gene, which are indicative of Basal Cell Nevus Syndrome (BCNS), also known as Gorlin Syndrome. This condition is characterized by the early onset of multiple basal cell carcinomas, jaw cysts, skeletal abnormalities, and a predisposition to other types of cancer. Early detection through genetic testing is crucial for managing and mitigating the symptoms and complications associated with BCNS.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the PTCH1 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with the syndrome. By opting for this test, individuals with a family history of BCNS or presenting related symptoms can gain valuable insights into their genetic health, enabling informed decisions regarding their medical care and surveillance for associated conditions.
The SUFU Gene Basal Cell Nevus Syndrome Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at identifying mutations in the SUFU gene, which are associated with Basal Cell Nevus Syndrome (BCNS). BCNS, also known as Gorlin syndrome, is a rare genetic condition that affects the skin, nervous system, eyes, endocrine system, and bones, leading to the development of multiple basal cell carcinomas and other abnormalities.
This genetic test is crucial for individuals with a family history of BCNS or those exhibiting symptoms of the syndrome, as early detection can significantly influence management and treatment options. By analyzing the DNA sample of the patient, the test can confirm the presence of specific genetic mutations in the SUFU gene, thereby aiding in the accurate diagnosis of BCNS.
The cost of the SUFU Gene Basal Cell Nevus Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to detect the genetic alterations linked to the syndrome, providing essential information for patients and healthcare providers to make informed decisions regarding the condition's management and preventive measures against potential complications.
